Institutional investors purchased a net $3.6 million shares of SPNC during the quarter ended June 2016 and now own 97.22% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POLAR CAPITAL LLP Bought 1.1 Million shares of Spectranetics Corp
ELK CREEK PARTNERS LLC Bought 503.7 Thousand shares of Spectranetics Corp
REDMILE GROUP LLC Bought 401.8 Thousand shares of Spectranetics Corp